Table 3 Medication outcome with Lovastatin use
Lovastatin N(%) | |||
|---|---|---|---|
Parameters (N = 501) | Monotherapy | Combination | χ 2 value |
Monitoing | |||
Total cholesterol | 416 (83.0) | 85 (17.0) | 0.001 |
High | 40 (9.6) | 12 (14.1) | |
Normal | 376 (90.4) | 73 (85.9) | 0.001 |
Triglycerides | |||
High | 75 (18.0) | 34 (40.0) | 0.001 |
Normal | 341 (82.0) | 51 (60.0) | |
Low-density Lipoprotein | |||
High | 42 (10.1) | 10 (11.8) | 0.025 |
Normal | 374 (89.9) | 73 (88.2) | |
High-Density Lipoprotein | |||
Low | 22 (5.3) | 5 (5.9) | 0.031 |
Normal | 394 (94.7) | 80 (94.1) | |
ALT | |||
High | 34 (8.2) | 10 (11.8) | 0.16 |
Normal | 382 (91.8) | 75 (88.2) | |
ALP | |||
High | 46 (11.0) | 5 (5.9) | 0.54 |
Normal | 370 (88.9) | 80 (94.1) | |
Hypertension | |||
YES | 324 (77.9) | 65 (76.5) | |
NO | 92 (22.1) | 20 (23.5) | 0.001 |
Adverse Effects | |||
YES | 14 (3.4) | 9 (10.6) | |
NO | 402 (96.6) | 76 (89.4) | 0.045 |